{"id":"W2003453345","doi":"10.1089/neu.2011.1765","title":"A Phase I/IIa Clinical Trial of a Recombinant Rho Protein Antagonist in Acute Spinal Cord Injury","year":2011,"lang":"en","type":"article","venue":"Journal of Neurotrauma","topic":"Spinal Cord Injury Research","field":"Medicine","cited_by":276,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia; Université de Montréal; University of Toronto","funders":"","keywords":"Medicine; Tolerability; Adverse effect; Spinal cord injury; Magnetic resonance imaging; Spinal cord; Clinical trial; Anesthesia; Population; Internal medicine; Radiology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002227932,0.0002183533,0.001059042,0.0005913117,0.00004015638,0.00001863913,0.0004198444,0.0001630674,0.0001830302],"category_scores_gemma":[0.001002652,0.0001699495,0.0004995325,0.0005228517,0.0003314243,0.0002098646,0.00009449106,0.001524755,0.00001828136],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008144977,"about_ca_system_score_gemma":0.000660743,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003688704,"about_ca_topic_score_gemma":0.00000432233,"domain_scores_codex":[0.9957982,0.0004255802,0.002241659,0.0002801848,0.000835995,0.0004183956],"domain_scores_gemma":[0.9976435,0.00006762626,0.001019088,0.0004287914,0.0004514494,0.0003895403],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8521511,0.007988746,0.001367219,0.0000874297,0.0001273059,0.003818408,0.0000367104,1.446279e-8,0.03653472,0.0000589074,0.0006095008,0.09721994],"study_design_scores_gemma":[0.1873442,0.7320216,0.04340418,0.001010409,0.0002612156,0.00231782,0.00007532375,0.00003939628,0.02937488,0.0003720816,0.003546961,0.000231955],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9962762,0.00005940897,0.00003996374,0.0007587203,0.0009548245,0.001294665,0.000005850352,0.00001035646,0.0005999834],"genre_scores_gemma":[0.9974725,0.0002169678,0.001446654,0.000153258,0.000415886,0.00001992766,9.827365e-7,0.00003774297,0.0002360497],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7240328,"threshold_uncertainty_score":0.6930341,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3525695971736482,"score_gpt":0.5272708957322941,"score_spread":0.174701298558646,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}